Cognition Disorders
84
4
5
55
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Research Maturity
55 completed trials (65% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
8.3%
7 terminated out of 84 trials
88.7%
+2.2% vs benchmark
15%
13 trials in Phase 3/4
16%
9 of 55 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 55 completed trials
Clinical Trials (84)
MRI Technical Development and Applications in Kidney Disease
Brain Stimulation and Cognitive Training for MCI
Influence of Individual Traits on Adaptation Processes in Individuals With Alcohol Use Disorder
Impact of Glasses for Vision Problems on Cognitive Function in Rural Older Adults
The BRAIN Intensive Care Unit (ICU) Study: Bringing to Light the Risk Factors
Westlake Aging Cohort (WeAC)
Dual-Task Improvement in Parkinson's Via rTMS
Neuropsychological Outcome After Cardiac Arrest
Supplementation of Inulin + L. Acidophilus in Elders with T2DM
Schizophrenia Cognition Scale Development
Development of a Prediction Model for Delirium After Cardiac Surgery Using a Novel Self-Administered Preoperative Cognitive Assessment Tool
Validation of a Novel Self-Administered Cognitive Assessment Tool (CogCheck) in Patients With Mild and Major Neurocognitive Disorder Predominantly Due to Alzheimer's Disease
Digital Game: A Scale to Evaluate the Perioperative Cognitive Function
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Dutch EASYcare Study
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
18F-AV-1451 PET Imaging in Participants Enrolled in the LEARN Study
A Precision Rehabilitation Approach to Counteract Age-Related Cognitive Declines
Cognitive Effects of Body Temperature During Hypothermic Circulatory Arrest
Safety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV Patients